file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
1401 | EQUINE | 3 | 7 | 31 |
1402 | FAILING | 2 | 7 | 47 |
1403 | HAMSTER | 2 | 7 | 31 |
1404 | HCV-INFECTED | 1 | 7 | 22 |
1405 | HEPATOCYTE | 5 | 7 | 109 |
1406 | ILEAL | 1 | 7 | 96 |
1407 | IMMUNOMODULATORY | 7 | 7 | 108 |
1408 | INFECTION | 19 | 7 | 317 |
1409 | INHIBIT | 6 | 7 | 261 |
1410 | INTOLERANCE | 1 | 7 | 10 |
1411 | INTRACTABLE | 2 | 7 | 26 |
1412 | INTRARENAL | 3 | 7 | 119 |
1413 | INTRAVENOUS | 8 | 7 | 97 |
1414 | ISOGRAFTS | 2 | 7 | 169 |
1415 | LEUCOCYTES | 1 | 7 | 24 |
1416 | LEUKEMIA | 5 | 7 | 67 |
1417 | LIFE-THREATENING | 1 | 7 | 18 |
1418 | LYMPHOCYTE-B | 2 | 7 | 125 |
1419 | LYMPHOCYTE-T | 2 | 7 | 125 |
1420 | MARKEDLY | 2 | 7 | 44 |
1421 | MECHANISM-BASED | 2 | 7 | 31 |
1422 | METHOTREXATE | 4 | 7 | 250 |
1423 | MICROVASCULAR | 3 | 7 | 72 |
1424 | MONOCLONAL | 8 | 7 | 147 |
1425 | MOTHER | 4 | 7 | 94 |
1426 | NEGLECT | 1 | 7 | 24 |
1427 | NIFEDIPINE | 2 | 7 | 113 |
1428 | NON-STEROID | 1 | 7 | 35 |
1429 | NUMBERS | 4 | 7 | 72 |
1430 | PAIRED | 1 | 7 | 127 |
# | Word | Recs | TLCS | TGCS |
1431 | PAST | 10 | 7 | 220 |
1432 | PD-L1 | 2 | 7 | 59 |
1433 | PHENYTOIN | 1 | 7 | 133 |
1434 | PLASMACYTOID | 2 | 7 | 57 |
1435 | PREFACE | 1 | 7 | 24 |
1436 | PROBES | 3 | 7 | 250 |
1437 | PRODUCT | 2 | 7 | 55 |
1438 | PROGENITOR-CELL | 1 | 7 | 19 |
1439 | PURIFIED | 3 | 7 | 48 |
1440 | RENIN | 6 | 7 | 175 |
1441 | REVISITED | 4 | 7 | 38 |
1442 | RODENTS | 3 | 7 | 31 |
1443 | S-ANTIGEN | 1 | 7 | 23 |
1444 | SAGA | 1 | 7 | 15 |
1445 | SECRETED | 3 | 7 | 68 |
1446 | SINGLE-CELL | 1 | 7 | 120 |
1447 | SINGLE-DAY | 1 | 7 | 25 |
1448 | STUDIED | 2 | 7 | 122 |
1449 | SURVIVORS | 4 | 7 | 42 |
1450 | T-REGULATORY | 1 | 7 | 45 |
1451 | TARGETS | 4 | 7 | 409 |
1452 | TEMPORARY | 2 | 7 | 58 |
1453 | TOLEROGENICITY | 2 | 7 | 27 |
1454 | TRANSPLANT-ASSOCIATED | 1 | 7 | 13 |
1455 | VERTEBRAL | 5 | 7 | 26 |
1456 | VESSELS | 1 | 7 | 50 |
1457 | WAITING | 1 | 7 | 16 |
1458 | WOUND | 6 | 7 | 214 |
1459 | 51CR-LABELLED | 1 | 6 | 103 |
1460 | ABROGATES | 2 | 6 | 16 |
# | Word | Recs | TLCS | TGCS |
1461 | ABROGATION | 1 | 6 | 15 |
1462 | ACHIEVABLE | 2 | 6 | 14 |
1463 | AHLS | 1 | 6 | 24 |
1464 | ALS | 6 | 6 | 34 |
1465 | ANTI-SCHISTOSOMAL | 1 | 6 | 109 |
1466 | ANTIBLAST | 1 | 6 | 80 |
1467 | ANTIBODY-DEPENDENT | 1 | 6 | 23 |
1468 | ARTERIAL | 6 | 6 | 159 |
1469 | ARTERIES | 2 | 6 | 34 |
1470 | AUTOTRANSPLANTATION | 3 | 6 | 73 |
1471 | BABOONS | 4 | 6 | 44 |
1472 | BILE | 5 | 6 | 166 |
1473 | BINDING | 3 | 6 | 147 |
1474 | BIOASSAYED | 1 | 6 | 15 |
1475 | BLEEDING | 3 | 6 | 69 |
1476 | BLOOD-CONCENTRATIONS | 1 | 6 | 37 |
1477 | BLOOD-TRANSFUSION | 7 | 6 | 68 |
1478 | COLONIC | 2 | 6 | 178 |
1479 | COMPLEMENT | 7 | 6 | 171 |
1480 | CORNEAL | 6 | 6 | 78 |
1481 | COUNTS | 1 | 6 | 38 |
1482 | CYTOTOXICITY | 3 | 6 | 109 |
1483 | DBMC | 1 | 6 | 10 |
1484 | DECREASED | 5 | 6 | 237 |
1485 | DEFINITION | 1 | 6 | 33 |
1486 | DEMONSTRATED | 2 | 6 | 75 |
1487 | DEPOSITS | 1 | 6 | 24 |
1488 | EFFECTIVENESS | 3 | 6 | 52 |
1489 | ELEMENTS | 1 | 6 | 21 |
1490 | ENDOTHELIAL-CELL | 1 | 6 | 73 |
# | Word | Recs | TLCS | TGCS |
1491 | EVALUATE | 1 | 6 | 15 |
1492 | EVER | 1 | 6 | 21 |
1493 | EXPLANATION | 1 | 6 | 8 |
1494 | FETAL-MATERNAL | 3 | 6 | 44 |
1495 | FK-506-INDUCED | 2 | 6 | 21 |
1496 | FOLLOWUP | 1 | 6 | 36 |
1497 | FOUR-COLOR | 1 | 6 | 10 |
1498 | HEPATITIS-B | 1 | 6 | 410 |
1499 | HEPATOCELLULAR | 4 | 6 | 2207 |
1500 | HINDLIMB | 2 | 6 | 16 |
1501 | HIPPURAN | 1 | 6 | 21 |
1502 | HORIZONS | 2 | 6 | 22 |
1503 | HPLC-MS | 1 | 6 | 37 |
1504 | HYPERLIPIDEMIA | 2 | 6 | 145 |
1505 | I-131-LABELED | 1 | 6 | 21 |
1506 | IMMUNE-RESPONSE | 2 | 6 | 79 |
1507 | IMMUNO-SUPPERSSION | 1 | 6 | 15 |
1508 | IMMUNOGLOBULIN-G | 1 | 6 | 24 |
1509 | INFUSION-INDUCED | 1 | 6 | 10 |
1510 | INTERLEUKIN-10 | 5 | 6 | 362 |
1511 | INTERLEUKIN-12 | 1 | 6 | 41 |
1512 | INTERLEUKIN-13 | 1 | 6 | 41 |
1513 | INTESTINE | 6 | 6 | 212 |
1514 | INTRAPORTAL | 4 | 6 | 10 |
1515 | KIDNEY-PANCREAS | 2 | 6 | 22 |
1516 | LATENT | 1 | 6 | 23 |
1517 | LEFLUNOMIDE | 3 | 6 | 149 |
1518 | LEVEL-GUIDED | 1 | 6 | 8 |
1519 | LOW | 9 | 6 | 74 |
1520 | LYMPHOBLASTIC | 2 | 6 | 50 |
# | Word | Recs | TLCS | TGCS |
1521 | MARKER | 6 | 6 | 104 |
1522 | MATCHED-PAIR | 1 | 6 | 47 |
1523 | MEASURE | 2 | 6 | 47 |
1524 | MEGADOSE | 1 | 6 | 10 |
1525 | MEIA | 1 | 6 | 37 |
1526 | MODELS | 6 | 6 | 96 |
1527 | MONO-AND | 1 | 6 | 52 |
1528 | MORPHOLOGY | 4 | 6 | 209 |
1529 | MULTI-LYMPHOID | 1 | 6 | 14 |
1530 | MYSTIQUE | 2 | 6 | 22 |
1531 | NEPHRITIS | 2 | 6 | 24 |
1532 | NEUROTOXICITY | 3 | 6 | 96 |
1533 | NONINHERITED | 1 | 6 | 99 |
1534 | PANCREATICODUODENAL | 4 | 6 | 19 |
1535 | PHARMACODYNAMICS | 1 | 6 | 61 |
1536 | PREDICTIVE | 4 | 6 | 105 |
1537 | PREDICTS | 3 | 6 | 9 |
1538 | PREFORMED | 4 | 6 | 27 |
1539 | PREGNANCY | 5 | 6 | 115 |
1540 | PREVENTS | 9 | 6 | 89 |
1541 | PRIMARILY | 2 | 6 | 70 |
1542 | PRIOR | 5 | 6 | 82 |
1543 | PROLINE | 4 | 6 | 354 |
1544 | PROTEIN-12 | 1 | 6 | 118 |
1545 | RE-EVALUATION | 1 | 6 | 12 |
1546 | REDUCING | 1 | 6 | 38 |
1547 | REPLICATION | 2 | 6 | 35 |
1548 | REQUIREMENTS | 2 | 6 | 58 |
1549 | RESEARCH | 9 | 6 | 57 |
1550 | REVERSES | 1 | 6 | 26 |
# | Word | Recs | TLCS | TGCS |
1551 | SEEDING | 1 | 6 | 14 |
1552 | SEX-MISMATCHED | 4 | 6 | 22 |
1553 | STOMATITIS | 1 | 6 | 24 |
1554 | SWITCHING | 3 | 6 | 147 |
1555 | T-LYMPHOCYTE-MEDIATED | 1 | 6 | 15 |
1556 | TACROLIMUS-BASED | 3 | 6 | 67 |
1557 | TECHNIQUES | 4 | 6 | 63 |
1558 | THROMBOSIS | 3 | 6 | 65 |
1559 | TISSUE-SPECIFIC | 1 | 6 | 24 |
1560 | TRAFFIC | 3 | 6 | 31 |
1561 | TRIPLE | 3 | 6 | 50 |
1562 | UNMODIFIED | 2 | 6 | 32 |
1563 | VARIABILITY | 2 | 6 | 183 |
1564 | VASCULAR-RESISTANCE | 1 | 6 | 73 |
1565 | VESICULAR | 1 | 6 | 24 |
1566 | WILL | 2 | 6 | 27 |
1567 | 10-YEAR | 3 | 5 | 50 |
1568 | 2ND | 2 | 5 | 110 |
1569 | ABSORPTION | 1 | 5 | 12 |
1570 | ABUNDANT | 1 | 5 | 18 |
1571 | ACTIVATION-INDUCED | 1 | 5 | 36 |
1572 | ADHESION | 4 | 5 | 106 |
1573 | ADOPTIVE | 2 | 5 | 66 |
1574 | ALCOHOLIC | 1 | 5 | 15 |
1575 | ALTERNATIVES | 2 | 5 | 78 |
1576 | ANALYZE | 2 | 5 | 13 |
1577 | ANTI-CD3 | 2 | 5 | 21 |
1578 | ANTI-CD45 | 1 | 5 | 27 |
1579 | ANTI-REJECTION | 1 | 5 | 46 |
1580 | APC | 1 | 5 | 10 |
# | Word | Recs | TLCS | TGCS |
1581 | APES | 1 | 5 | 29 |
1582 | APPEARANCES | 1 | 5 | 94 |
1583 | AVOIDING | 1 | 5 | 19 |
1584 | B10 | 1 | 5 | 28 |
1585 | BATCH | 2 | 5 | 12 |
1586 | BB-RATS | 1 | 5 | 25 |
1587 | BREAKTHROUGH | 1 | 5 | 11 |
1588 | CANDIDACY | 1 | 5 | 15 |
1589 | CARDIOVASCULAR | 3 | 5 | 53 |
1590 | CAUSED | 5 | 5 | 45 |
1591 | CD4 | 4 | 5 | 45 |
1592 | CELL-DEATH | 1 | 5 | 36 |
1593 | CELLULOSE | 1 | 5 | 12 |
1594 | CHARACTERISTICS | 4 | 5 | 75 |
1595 | CHOLESTATIC | 2 | 5 | 126 |
1596 | CHRONICALLY | 1 | 5 | 6 |
1597 | COLLAPSE | 1 | 5 | 5 |
1598 | COMPOUNDS | 3 | 5 | 69 |
1599 | CYP3A4 | 1 | 5 | 35 |
1600 | DAMAGE | 7 | 5 | 70 |